The global 3D printed surgical models market size is expected to reach USD 1.1 billion by 2026, expanding at a CAGR of 10.3%, according to a new report by Grand View Research, Inc. Improving diagnosis as well as the context of the patient’s pathology is driving the market. Increasing use of advanced healthcare technologies for better understanding of patients and minimization of risk during the actual surgical procedure is boosting the demand for 3D printed surgical models.
The introduction of synthetic modeling of human anatomy has made a significant leap forward. The 3D printed surgical models allow preadoption of surgical instruments by improving the 3D perception of the planned operation. The technology also enables surgeons to envision, practice, and then perform the actual surgery for saving time and increasing precision. These models can also be used to perform mock surgeries, thereby improving the prediction of the outcomes.
Advanced medical models are anatomically accurate, highly functional, and biomechanically realistic and are liberated from the cost and inconvenience to the animal as well as cadaver labs. They are perfect for simulating clinical procedures such as suturing, cutting, reaming, drilling, and even device placement. Some of the most advanced three-dimensional structures can even mimic bleeding, coming as close as possible to reality, which would enhance the efficiency and accuracy of surgical procedures.
The 3D printed anatomical models can help in numerous aspects, including educating young surgeons about tactile and three-dimensional inspection of the tissues. They are also used to help patients prepare for surgery.
Click the link below:
Further key findings from the study suggest:
- The orthopedic surgery segment accounted for highest revenue in 2018 as the 3D models can assist in pre-operative planning by defining the geometry of bone loss, tumor mass, and nearby vessels to determine the most appropriate osteotomy site along with most appropriate prosthesis
- The neurosurgery segment is anticipated to witness the fastest CAGR of 11.3% over the forecast period. This is due to increase in the use of 3D models to describe complex anatomical structures to patients
- North America held the largest share accounting for 35.3% of the global market share in 2018. This is attributed to the U.S. offering the most sophisticated healthcare infrastructure comprising multispecialty hospitals and clinics, thereby increasing the demand
- Some of the players operating in the market are Stratasys, Ltd.; 3D Systems, Inc.; Lazarus 3D, LLC; Osteo3d; Axial3D; Onkos Surgical; Formlabs, Materialise NV; 3D LifePrints UK Ltd.; and WhiteClouds.